Ignite Creation Date:
2025-12-26 @ 5:21 PM
Ignite Modification Date:
2025-12-31 @ 11:29 AM
Study NCT ID:
NCT05848206
Status:
COMPLETED
Last Update Posted:
2023-05-08
First Post:
2023-04-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Impact of Formulary Coverage of Entresto (Sacubitril/Valsartan) on Prescription Abandonment/Rejection and Subsequent Treatment and Economic Outcomes in Chronic Heart Failure Patients in the U.S.
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-11
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-29
Completion Date Type:
ACTUAL
First Submit Date:
2023-04-27
First Submit QC Date:
None
Study First Post Date:
2023-05-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-27
Last Update Post Date:
2023-05-08
Last Update Post Date Type:
ACTUAL